Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Other Operating Expenses: 2018-2025

Historic Other Operating Expenses for Organogenesis Holdings (ORGO) over the last 2 years, with Sep 2025 value amounting to $37.2 million.

  • Organogenesis Holdings' Other Operating Expenses rose 38.73% to $37.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.6 million, marking a year-over-year change of. This contributed to the annual value of $22.8 million for FY2024, which is N/A change from last year.
  • As of Q3 2025, Organogenesis Holdings' Other Operating Expenses stood at $37.2 million, which was up 26.54% from $29.4 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Other Operating Expenses ranged from a high of $52.0 million in Q2 2024 and a low of -$84.7 million during Q4 2024.
  • Over the past 2 years, Organogenesis Holdings' median Other Operating Expenses value was $28.1 million (recorded in 2024), while the average stood at $11.2 million.
  • Over the last 5 years, Organogenesis Holdings' Other Operating Expenses had its largest YoY gain of 38.73% in 2025, and its largest YoY loss of 43.51% in 2025.
  • Over the past 2 years, Organogenesis Holdings' Other Operating Expenses (Quarterly) stood at -$84.7 million in 2024, then spiked by 38.73% to $37.2 million in 2025.
  • Its last three reported values are $37.2 million in Q3 2025, $29.4 million for Q2 2025, and $6.6 million during Q1 2025.